Interleukin-22 Is Required For Promotion Of K-Ras Mutant Lung Cancer

被引：0
|
作者：
Khosravi, N. [1 ]
Cumpian, A. M. [1 ]
Caetano, M. [1 ]
Daliri, S. [1 ]
Moghaddam, S. J. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3669
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Antitumor activity of YAP1 inhibitor in K-Ras mutant lung cancer cells
    Shimomura, Iwao
    Yamamoto, Yusuke
    Tada, Yuji
    Tatsumi, Koichiro
    Ochiya, Takahiro
    CANCER SCIENCE, 2018, 109 : 1182 - 1182
  • [22] A catch-22: Interleukin-22 and cancer
    Hernandez, Pedro
    Gronke, Konrad
    Diefenbach, Andreas
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (01) : 15 - 31
  • [23] Targeting IL-6 as a preventive and therapeutic strategy for K-ras mutant lung cancer
    Caetano, Mauricio S.
    Cumpian, Amber M.
    Gong, Lei
    Chang, Seon H.
    Zhang, Huiyuan
    Kadara, Humam N.
    Sternberg, Cinthya
    Ferreira, Carlos G.
    Watowich, Stephanie S.
    Moghaddam, Seyed J.
    CANCER RESEARCH, 2015, 75
  • [24] Efficacy of siRNA-loaded nanoparticles in the treatment of K-RAS mutant lung cancer in vitro
    Gencer, Ayse
    Baysal, Ipek
    Nemutlu, Emirhan
    Yabanoglu-Ciftci, Samiye
    Arica, Betul
    JOURNAL OF MICROENCAPSULATION, 2022, 39 (03) : 261 - 275
  • [25] K-ras mutations as molecular markers of lung cancer
    Jacobson, DR
    CLINICAL AND BIOLOGICAL BASIS OF LUNG CANCER PREVENTION, 1998, : 169 - 183
  • [26] K-ras mutations in lung cancer: The "mysterious mutation"
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2006, 8 (01) : 11 - 12
  • [27] Targeting interleukin-22 for cancer therapy
    Markota, Anamarija
    Endres, Stefan
    Kobold, Sebastian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 2012 - 2015
  • [28] Interleukin-22 - A potential immunomodulatory molecule in the lung
    Whittington, HA
    Armstrong, L
    Uppington, KM
    Millar, AB
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (02) : 220 - 226
  • [29] Generation of a ribozyme-adenoviral vector against K-ras mutant human lung cancer cells
    Zhang, YA
    Nemunaitis, J
    Tong, AW
    MOLECULAR BIOTECHNOLOGY, 2000, 15 (01) : 39 - 49
  • [30] Generation of ribozyme-adenoviral vector against K-ras mutant human lung cancer cells
    Yu-An Zhang
    John Nemunaitis
    Alex W. Tong
    Molecular Biotechnology, 2000, 15 : 39 - 49
12345